Clinical Trial Update: Efficacy and Tolerability of ABB I5 Prebiotic and ABB C22 Postbiotics for the Management of Constipation and Gastrointestinal Well-being: a Pilot Trial [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 pilot trial update evaluating the efficacy and tolerability of ABB I5 Prebiotic and ABB C22 Postbiotics for constipation and overall gastrointestinal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation

Drugs mentioned

• ABB C22 Postbiotics
• ABB I5 Prebiotic

Snippet

Sponsor: AB Biotek | Conditions: Constipation | EARLY_Phase 1 | Status: COMPLETED